Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.49 |
| ▸ | FAAH | O00519 | 2/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.44 |
| ▸ | CETP | P11597 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11895906 | 0.98 | EPHX2 (0.47) | EPHX2FAAHCNR1CNR2PPARA | |
| SCHEMBL11895904 | 0.98 | EPHX2 (0.47) | EPHX2FAAHCNR1CNR2PPARA | |
| SCHEMBL27731616 | 0.93 | TSHR (0.47) | EPHX2FAAHCNR1CNR2CETP | |
| SCHEMBL14496883 | 0.87 | TDP1 (0.50) | EPHX2FAAHCNR1CNR2PPARA | |
| SCHEMBL23533338 | 0.87 | EPHX2 (0.49) | EPHX2FAAHCNR1CNR2PPARA | |
| SCHEMBL23533340 | 0.87 | EPHX2 (0.49) | EPHX2FAAHCNR1CNR2PPARA | |
| SCHEMBL9197255 | 0.87 | TDP1 (0.50) | EPHX2FAAHCNR1CNR2PPARA | |
| SCHEMBL23533392 | 0.87 | EPHX2 (0.49) | EPHX2FAAHCNR1CNR2PPARA | |
| SCHEMBL14496882 | 0.87 | TDP1 (0.50) | EPHX2FAAHCNR1CNR2PPARA | |
| SCHEMBL9197227 | 0.87 | TDP1 (0.50) | EPHX2FAAHCNR1CNR2PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993025521-A1 | ARYL ALIPHATIC ACIDS | BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) | 1993-12-23 | — | — | WO | disclosed |